Gengos Andrew's Form 4 filing
LeonaBio, Inc. (LONA) · filed Jan 8, 2024
- Accession no.
- 0001209191-24-001153
- Filed
- Jan 8, 2024
- Trade date
- Jan 4-5, 2023
- Filing delay
- 369 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.52K. It was filed 369 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001415889-24-004149 (Feb 16, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gengos AndrewCIK 0001563623 | Officer (See Below) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Common Stock | AGrant or awardAcquired | +5,000 | $0.00 | $0 | 85,012 | Direct | |
| Jan 5, 2023 | Common Stock | SSaleDisposed | −1,208 | $2.91 | −$3,515.28 | 83,804 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.